Newly Published Phase 3 SAPPHIRE Study Highlight Therapeutic
Potential of Apitegromab in Spinal Muscular Atrophy
Scholar Rock’s phase 3 SAPPHIRE trial of apitegromab revealed that the treatment led to improved…














